Intragastric Balloons Market by Region, America (Us, Canada, Brazil, Rest of America) Europe, Middle East, and Africa (Germany, UK, France, Italy, Spain) Rest of Europe (Middle East, Africa, Asia-pacific, Japan, China, India) Forecast 2015-2022.
The Intragastric Balloons are used for weight loss. They are saline-filled silicone balloons placed in the stomach for a span of months and limit the intake of food by giving the feeling of satiety. The Intragastric Balloons market was valued at US$136.64 million in 2016 and is expected to reach US$215.92 million by 2023 growing at a CAGR of 6.75% during the forecast period 2017-2023.
In 2016, Obesity has been estimated to cost the EU US$ 78.09 billion annually through healthcare costs and lost productivity. The US and the Gulf countries have the highest rate of obesity. Factors such as the presence of a large obese population change in lifestyle, reduced hospital stay, short recovery time, and availability of low-priced intragastric balloons is driving the growth of the market. However, limitations and adverse events of intragastric balloons are likely to limit the adoption of this technology.
Learn more Full Market Insight Details here: https://www.inkwoodresearch.com/reports/global-intragastric-balloons-market-forecast-2017-2023/
The Intragastric balloons market in Europe, Middle East, and Africa (EMEA) was valued at $85.81 million in 2016 and is expected to reach $131.71 million by 2023, growing at a CAGR of 6.31% during the forecast period. Americas’ market was valued at $38.72 million in 2016 and is expected to reach $66.94 million by 2023, growing at a CAGR of 8.14% during the forecast period. This market in APAC was valued at $12.12 million in 2016 and is expected to reach $17.27 million by 2023, growing at a CAGR of 5.20% during the forecast period.
The Intragastric balloons market is highly competitive with the presence of large, medium, and small players. Some of the major players in this market are Apollo Endoscopy Inc., Spatz FGIA Inc., Allurion Technologies Inc., ReShape Medical Inc., Hélioscopie SA, and Obalon Therapeutics Inc.
Browse Healthcare Reports of Inkwood Research @ https://www.inkwoodresearch.com/reports/category/healthcare/